Rocket Pharmaceuticals (RCKT) Depreciation and Depletion (2015 - 2020)
Rocket Pharmaceuticals (RCKT) reported Depreciation and Depletion of $100000.0 for Q2 2020, little changed on a YoY basis from $100000.0 in Q3 2019, and down 15.25% sequentially from $118000.0 in Q1 2020.
Rocket Pharmaceuticals (RCKT) Depreciation and Depletion (2015 - 2020) Analysis & Trends
Rocket Pharmaceuticals (RCKT) has 6 years of Depreciation and Depletion data on file, last reported at $100000.0 in Q2 2020.
- For the quarter ending Q2 2020, Depreciation and Depletion changed 0.0% year-over-year to $100000.0; the trailing twelve-month figure through Jun 2020 stood at $419000.0 (up 5.01% YoY), and the FY2019 full-year result was $426000.0, up 29.09% from the prior year.
- Depreciation and Depletion slipped to $100000.0 in Q2 2020, from $118000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $118000.0 in Q1 2020 to a low of -$44000.0 in Q4 2016.
- A 5-year average of $69277.8 and a median of $78500.0 in 2018 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 3500.0% in 2016, while the deepest fall reached 215.79% in 2016.
- Tracing RCKT's Depreciation and Depletion over 5 years: stood at -$44000.0 in 2016, then soared by 240.91% to $62000.0 in 2017, then soared by 56.45% to $97000.0 in 2018, then climbed by 4.12% to $101000.0 in 2019, then slipped by 0.99% to $100000.0 in 2020.
- Business Quant data shows RCKT's Depreciation and Depletion at $100000.0 in Q2 2020, $118000.0 in Q1 2020, and $101000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Rocket Pharmaceuticals | 357.93 Mn | 357.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 100,000.00 |
| Mar 31, 2020 | 118,000.00 |
| Mar 31, 2020 | 118,000.00 |
| Dec 31, 2019 | 101,000.00 |
| Dec 31, 2019 | 101,000.00 |
| Sep 30, 2019 | 100,000.00 |
| Sep 30, 2019 | 100,000.00 |
| Jun 30, 2019 | 100,000.00 |
| Jun 30, 2019 | 100,000.00 |
| Mar 31, 2019 | 102,000.00 |
| Mar 31, 2019 | 102,000.00 |
| Dec 31, 2018 | 97,000.00 |
| Dec 31, 2018 | 97,000.00 |
| Sep 30, 2018 | 100,000.00 |
| Sep 30, 2018 | 100,000.00 |
| Jun 30, 2018 | 74,000.00 |
| Jun 30, 2018 | 74,000.00 |
| Mar 31, 2018 | 83,000.00 |
| Mar 31, 2018 | 83,000.00 |